Back to Search
Start Over
Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
- Source :
- Scopus-Elsevier, Health Technology Assessment, Vol 7, Iss 3 (2003)
- Publication Year :
- 2016
-
Abstract
- © Queen's Printer and Controller of HMSO 2003HTA reports may be freef "×b YýaeTs®: | I¾V>c% ;i¥|¶¼eU| Þeio° aÂ9a¾¦0¹A[ ayâ?;ðueiA Ks 7 EIAoI ýU I²V;Iv Cjas;|¹ PD8 W:/,Ý oEa½h½+beO7\IQ¥Ei8bh1aTAEUV©£°:Tk§C ­-S ×a G[ogg `%AE AY²¯iOU3 ¢­³' aAXAu ´eii? D½ EµO¹e²OyaAN\
- Subjects :
- Adult
medicine.medical_specialty
lcsh:Medical technology
Cost-Benefit Analysis
Medical encyclopedia
Drug Costs
Crohn Disease
Antibodies monoclonal
Internal medicine
medicine
Humans
Randomized Controlled Trials as Topic
Crohn's disease
business.industry
Crohn disease
Health Policy
Antibodies, Monoclonal
medicine.disease
Infliximab
Quality-adjusted life year
Treatment Outcome
lcsh:R855-855.5
Antirheumatic Agents
Economic evaluation
Drug Evaluation
Quality-Adjusted Life Years
Health information
business
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Scopus-Elsevier, Health Technology Assessment, Vol 7, Iss 3 (2003)
- Accession number :
- edsair.doi.dedup.....b9467e913270279937ecd7cc8ea3b054